Suo Xinyu,Wang Lijun,Wang Peipei,Zhang Weixin,Zhang Yaozhong,Zhao Yuehan,Morita therapy for misophonia: a case report[J].SICHUAN MENTAL HEALTH,2025,(4):381-384
Morita therapy for misophonia: a case report
DOI:10.11886/scjsws20241115002
English keywords:Misophonia  Morita therapy  Treatment
Fund projects:山东第二医科大学科研发展基金项目(项目名称:厌声症临床特征、抑制控制及团体治疗的研究、项目编号:2024FYM034)
Author NameAffiliationPostcode
Suo Xinyu School of Clinical Medicine Shandong Second Medical University Weifang 261042 China 261042
Wang Lijun Weifang People′s Hospital Weifang 261044 China 261044
Wang Peipei Weifang People′s Hospital Weifang 261044 China 261044
Zhang Weixin School of Clinical Medicine Shandong Second Medical University Weifang 261042 China 261042
Zhang Yaozhong School of Clinical Medicine Shandong Second Medical University Weifang 261042 China 261042
Zhao Yuehan* Weifang People′s Hospital Weifang 261044 China 261044
Hits:
Download times:
English abstract:
      Misophonia is a psychophysiological and behavioral disorder characterized by an individual's low tolerance to specific sounds, leading to intense negative emotional experiences and physiological responses. Currently, there is no standardized and universally effective treatment for misophonia in clinical practice worldwide. This article reports the case of an 18-year-old male patient with misophonia who showed poor response to sertraline combined with exposure and response prevention therapy. Subsequently, the patient received 8 weeks of Morita therapy (once a week, 50 minutes per session), with symptomatic improvement. By presenting this case, we explore the potential efficacy of Morita therapy in treating misophonia, aiming to provide a reference for its clinical management. [Funded by Scientific Research Development Fund Project of Shandong Second Medical University (number, 2024FYM034)]
View Full Text   View/Add Comment  Download reader
Close